Teva May have a Problem Resulting from Opioid Epidemic: Barbuto & Johansson, P.A. Updates Investors of Class Action Lawsuit Against Teva Pharmaceutical
July 23, 2019 12:04 ET | Barbuto & Johansson
WELLINGTON, Fla., July 23, 2019 (GLOBE NEWSWIRE) -- Barbuto & Johansson, P.A. (“BARJO”) and Of Counsel, Neil Rothstein, Esq. (with over 30 years of Securities Class Action Experience, including...
Schall Firm Logo 2.jpg
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
July 22, 2019 13:40 ET | Schall Law
LOS ANGELES, July 22, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Teva Pharmaceutical...
Barbuto & Johansson, P.A. reminds TEVA, EQT, FRED and RBGLY Shareholders of Class Action Deadlines
July 18, 2019 11:04 ET | Barbuto & Johansson
WELLINGTON, Fla., July 18, 2019 (GLOBE NEWSWIRE) -- Barbuto & Johansson, P.A. (“BARJO”) and Of Counsel, Neil Rothstein, Esq. (with over 30 years of Securities Class Action Experience, including...
Schall Firm Logo 2.jpg
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
July 16, 2019 10:19 ET | Schall Law
LOS ANGELES, July 16, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Teva Pharmaceutical...
Schall Firm Logo 2.jpg
INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
July 09, 2019 09:59 ET | Schall Law
LOS ANGELES, July 09, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Teva Pharmaceutical...
BARJO LAW INVESTOR ALERT: Barbuto & Johansson, P.A. Advises TUSK, TEVA, COTY and NOAH Shareholders of Class Action Lawsuits and Investigations
July 08, 2019 22:59 ET | Barbuto & Johansson
WELLINGTON, Fla., July 08, 2019 (GLOBE NEWSWIRE) -- Barbuto & Johansson, P.A. (“BARJO”) and Of Counsel, Neil Rothstein, Esq. (with over 30 years of Securities Class Action Experience, including...
Schall Firm Logo 2.jpg
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
July 02, 2019 10:27 ET | Schall Law
LOS ANGELES, July 02, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Teva Pharmaceutical...
Barbuto & Johansson, P.A. Informs Investors of the Pending Class Action Lawsuit Against Teva Pharmaceutical and Encourages Investors to Contact the Firm
July 01, 2019 03:00 ET | Barbuto & Johansson
WELLINGTON, Fla., July 01, 2019 (GLOBE NEWSWIRE) -- Barbuto & Johansson, P.A. (“BARJO”) and Of Counsel, Neil Rothstein, Esq. (with over 30 years of Securities Class Action Experience, including...
Schall Firm Logo 2.jpg
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
June 27, 2019 10:47 ET | Schall Law
LOS ANGELES, June 27, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Teva Pharmaceutical...
logo.jpg
The US Supreme Court Grants Review for Certiorari of a Federal Circuit Panel Ruling that US Patent Protection for Aloxi® in the US Market was Invalid
June 26, 2018 11:59 ET | Helsinn Healthcare S.A.
The US Supreme Court Grants Review for Certiorari of a Federal Circuit Panel Ruling that US Patent Protection for Aloxi® in the US Market was Invalid Lugano, Switzerland, June 26, 2018 – The United...